The World's Greatest Investing Community
Results 1 - 10 of 29 : 1 2 3 Next
Ligand Pharmaceuticals Crushes Estimates
Just the facts, Fool.
These stocks just rolled over. Can they come back?
Reshuffling Yahoo!'s Board: A New House of Cards?
It may take an activist shareholder to bring about meaningful change.
3 Stocks Near 52-Week Highs Worth Selling
Are these stocks sells or belles? You be the judge!
12 Biotech Stocks the Insiders Are Buying
Folks in the know think these stocks will rise. Should you join them?
This Just In: Upgrades and Downgrades
Oppenheimer opts to buy Aeterna Zentaris.
What goes down, must come up. (Or must it?)
Investors still think highly of these companies, despite their fire-sale prices.
It can pay to catch rising stars.
Pharma's Next Home Run Drug Could Be 4 Singles Instead
With mixed success in the women's health field, drugmakers try to turn a single compound into a treatment for several diseases and conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK